Skip to main content

Advertisement

Log in

Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Giant cell tumour of bone (GCTB) is a primary tumour of bone that may rarely, in the absence of malignant cytological features, produce metastatic lesions, most commonly in the lungs. Whether these lung nodules represent true neoplastic secondaries or implants derived from the primary tumour is not certain. In this study, we have analysed the morphological and immunophenotypic features of 19 conventional GCTBs and corresponding lung nodules for expression of macrophage, osteoclast, proliferation and tumour-associated markers. A striking morphological feature of all GCTBs that produced lung secondaries was the presence of large areas of haemorrhage and thrombus formation; mononuclear and multinucleated cells of GCTB were frequently found within these areas of haemorrhage and thrombus. A similar pattern of CD14, CD33, HLA-DR and CD51 expression was seen in macrophages and giant cells in primary and secondary tumours. Smooth muscle actin expression was frequently noted in primary GCTBs that recurred and metastasised. No difference was seen in the expression of p53, p63, Ki-67, cyclin D1 or Bcl-2 in primary and secondary tumours. Our findings suggest that most lung nodules associated with primary conventional GCTBs are implants derived from tumour emboli formed in areas of haemorrhage and thrombus formation within the primary tumour.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Reid R, Bareyce SS, Sciot R (2002) Giant cell tumour. In: Fletcher C, Unni K, Mertens F (eds) Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon, pp 310–312

    Google Scholar 

  2. Unni K, Inwards C, Bridge J et al (2005) Tumours of the bones and joints. AFIP Atlas of Tumour Pathology Fourth Series, AFIP, pp 281–298

  3. Geshickter CF, Copeland MM (1930) Recurrent and so-called metastatic giant cell tumour. Arch Surg 20(5):714–755

    Google Scholar 

  4. Turcotte RE (2006) Giant cell tumour of bone. Orthop Clin N Am 32:35–51

    Article  Google Scholar 

  5. Bertoni F, Present D, Sudanese A et al (1988) Giant cell tumour of bone with pulmonary metastases. Clin Orthop 237:275–285

    PubMed  Google Scholar 

  6. Rock MG, Pritchard DJ, Unni KK (1984) Metastases from histologically benign giant-cell tumour of bone. J Bone Joint Surg 66N:269–273

    Google Scholar 

  7. Tubbs WS, Brown LR, Beabout JW et al (1992) Benign giant-cell tumour of bone with pulmonary metastases. AJR 158:331–334

    CAS  PubMed  Google Scholar 

  8. Faisham WI, Zulmi W, Saim AH et al (2004) Pulmonary metastases of giant cell tumour of the bone. Med J Malaysia 59(Suppl F):78–81

    PubMed  Google Scholar 

  9. Maloney WJ, Vaughan LM, Jones HH et al (1989) Benign metastasizing giant cell tumour of bone. Clin Orthop 243:208–215

    PubMed  Google Scholar 

  10. Huvos AG (1991) Bone tumours: diagnosis, treatment and prognosis. Saunders, Philadelphia, pp 429–467

    Google Scholar 

  11. Mirra JM, Ulich T, Magidson J et al (1982) A case of probable benign pulmonary “metastases” or implants arising from a giant cell tumour of bone. Clin Orthop 162:245–254

    PubMed  Google Scholar 

  12. Forsyth RG, De Boeck G, Baeide JJ et al (2009) CD33+ CD14− phenotype is characteristic of multinuclear osteoclast-like cells in giant cell tumour of bone. J Bone Miner Res 24:70–77

    Article  CAS  PubMed  Google Scholar 

  13. Lau YS, Sabokbar A, Gibbons CL et al (2005) Phenotypic and molecular studies of giant-cell tumours of bone and soft tissue. Hum Pathol 36:945–954

    Article  CAS  PubMed  Google Scholar 

  14. Bertoni F, Present D, Enneking WF (1985) Giant-cell tumour of bone with pulmonary metastases. J Bone Joint Surg 67A:890–900

    Google Scholar 

  15. Forest M (1988) Orthopaedic surgical pathology: diagnosis of tumours and pseudotumoral lesions of bone and joint. Churchill Livingstone, New York, pp 423–428

    Google Scholar 

  16. Dickson BC, Li SQ, Wunder JS et al (2008) Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumour of the bone. Mod Pathol 21:531–539

    Article  CAS  Google Scholar 

  17. Ladanyi M, Traganos F, Huvos AG (1989) Benign metastasizing giant cell tumours of bone. A DNA flow cytometric study. Cancer 64:1521–1526

    Article  CAS  PubMed  Google Scholar 

  18. Osaka S, Toriyama M, Taira K et al (1997) Analysis of giant cell tumour of bone with pulmonary metastases. Clin Orthop 335:253–261

    PubMed  Google Scholar 

  19. Osaka S, Sugita H, Osaka E et al (2004) Clinical and immunohistochemical characteristics of benign giant cell tumour of bone with pulmonary metastases: case series. Orthop Surg 12:55–62

    CAS  Google Scholar 

  20. Forsyth RG, De Boeck G, Bekaert S et al (2008) Telomere biology in giant cell tumour of bone. J Pathol 214:555–563

    Article  CAS  PubMed  Google Scholar 

  21. de Souza PE, Paim JF, Carvalhais JN et al (1999) Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumour. J Oral Pathol Med 28:54–58

    Article  PubMed  Google Scholar 

  22. Ueda Y, Dockhorn-Dworniczak B, Blasius S et al (1993) Analysis of mutant p53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol 119:172–178

    Article  CAS  PubMed  Google Scholar 

  23. Rao UN, Goodman M, Chung WW et al (2005) Molecular analysis of primary and recurrent giant cell tumours of bone. Cancer Genet Cytogenet 158:126–136

    Article  CAS  PubMed  Google Scholar 

  24. Masui F, Ushigome S, Fujii K (1998) Giant cell tumour of bone: a clinicopathologic study of prognostic factors. Pathol Int 48:723–729

    Article  CAS  PubMed  Google Scholar 

  25. Sulh MA, Greco MA, Jiang T et al (1996) Proliferation index and vascular density of giant cell tumours of bone: are they prognostic markers? Cancer 77:2044–2051

    Article  CAS  PubMed  Google Scholar 

  26. Lindeman JH, Hanemaaijer R, Mulder A et al (2004) Cathepsin K is the principal protease in giant cell tumour of bone. Am J Pathol 165:593–600

    CAS  PubMed  Google Scholar 

Download references

Acknowledgement

The authors are members of EuroBoNet, a European Network of Excellence studying the pathology and genetics of bone tumours. The authors thank Chris Lowe for typing the manuscript.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. A. Athanasou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alberghini, M., Kliskey, K., Krenacs, T. et al. Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone. Virchows Arch 456, 97–103 (2010). https://doi.org/10.1007/s00428-009-0863-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-009-0863-2

Keywords

Navigation